216 related articles for article (PubMed ID: 27313208)
41. Interaction of the receptor FGFRL1 with the negative regulator Spred1.
Zhuang L; Villiger P; Trueb B
Cell Signal; 2011 Sep; 23(9):1496-504. PubMed ID: 21616146
[TBL] [Abstract][Full Text] [Related]
42. Effect of neurofibromatosis type I mutations on a novel pathway for adenylyl cyclase activation requiring neurofibromin and Ras.
Hannan F; Ho I; Tong JJ; Zhu Y; Nurnberg P; Zhong Y
Hum Mol Genet; 2006 Apr; 15(7):1087-98. PubMed ID: 16513807
[TBL] [Abstract][Full Text] [Related]
43. The GTPase-activating protein-related domain of neurofibromin interacts with MC1R and regulates pigmentation-mediated signaling in human melanocytes.
Deraredj Nadim W; Hassanaly S; Bénédetti H; Kieda C; Grillon C; Morisset-Lopez S
Biochem Biophys Res Commun; 2021 Jan; 534():758-764. PubMed ID: 33187641
[TBL] [Abstract][Full Text] [Related]
44. PKA phosphorylation and 14-3-3 interaction regulate the function of neurofibromatosis type I tumor suppressor, neurofibromin.
Feng L; Yunoue S; Tokuo H; Ozawa T; Zhang D; Patrakitkomjorn S; Ichimura T; Saya H; Araki N
FEBS Lett; 2004 Jan; 557(1-3):275-82. PubMed ID: 14741381
[TBL] [Abstract][Full Text] [Related]
45. Role of TC21/R-Ras2 in enhanced migration of neurofibromin-deficient Schwann cells.
Huang Y; Rangwala F; Fulkerson PC; Ling B; Reed E; Cox AD; Kamholz J; Ratner N
Oncogene; 2004 Jan; 23(2):368-78. PubMed ID: 14724565
[TBL] [Abstract][Full Text] [Related]
46. Review and update of SPRED1 mutations causing Legius syndrome.
Brems H; Pasmant E; Van Minkelen R; Wimmer K; Upadhyaya M; Legius E; Messiaen L
Hum Mutat; 2012 Nov; 33(11):1538-46. PubMed ID: 22753041
[TBL] [Abstract][Full Text] [Related]
47. Structural and biochemical consequences of NF1 associated nontruncating mutations in the Sec14-PH module of neurofibromin.
Welti S; Kühn S; D'Angelo I; Brügger B; Kaufmann D; Scheffzek K
Hum Mutat; 2011 Feb; 32(2):191-7. PubMed ID: 21089070
[TBL] [Abstract][Full Text] [Related]
48. Neurofibromin Structure, Functions and Regulation.
Bergoug M; Doudeau M; Godin F; Mosrin C; Vallée B; Bénédetti H
Cells; 2020 Oct; 9(11):. PubMed ID: 33121128
[TBL] [Abstract][Full Text] [Related]
49. Human breast cancer MDA-MB-231 cells fail to express the neurofibromin protein, lack its type I mRNA isoform and show accumulation of P-MAPK and activated Ras.
Ogata H; Sato H; Takatsuka J; De Luca LM
Cancer Lett; 2001 Oct; 172(2):159-64. PubMed ID: 11566491
[TBL] [Abstract][Full Text] [Related]
50. ras effector loop mutations that dissociate p120GAP and neurofibromin interactions.
Stang S; Bottorff D; Stone JC
Mol Carcinog; 1996 Jan; 15(1):64-9. PubMed ID: 8561868
[TBL] [Abstract][Full Text] [Related]
51. [Relationship between Spred1 and acute myeloid leukemia].
Zhang Y; Li Y; Zhang R
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):1083-7. PubMed ID: 23998617
[TBL] [Abstract][Full Text] [Related]
52. Restoring functional neurofibromin by protein transduction.
Mellert K; Lechner S; Lüdeke M; Lamla M; Möller P; Kemkemer R; Scheffzek K; Kaufmann D
Sci Rep; 2018 Apr; 8(1):6171. PubMed ID: 29670214
[TBL] [Abstract][Full Text] [Related]
53. The Sprouty-related protein, Spred, inhibits cell motility, metastasis, and Rho-mediated actin reorganization.
Miyoshi K; Wakioka T; Nishinakamura H; Kamio M; Yang L; Inoue M; Hasegawa M; Yonemitsu Y; Komiya S; Yoshimura A
Oncogene; 2004 Jul; 23(33):5567-76. PubMed ID: 15184877
[TBL] [Abstract][Full Text] [Related]
54. The GAP-related domain of neurofibromin attenuates proliferation and downregulates N- and K-Ras activation in Nf1-negative AML cells.
Morgan KJ; Rowley MA; Wiesner SM; Hasz DE; Van Ness B; Largaespada DA
Leuk Res; 2007 Aug; 31(8):1107-13. PubMed ID: 17222906
[TBL] [Abstract][Full Text] [Related]
55. Differences in the interaction of p21c-Ha-ras-GMP-PNP with full-length neurofibromin and GTPase-activating protein.
DiBattiste D; Golubic M; Stacey D; Wolfman A
Oncogene; 1993 Mar; 8(3):637-43. PubMed ID: 8437847
[TBL] [Abstract][Full Text] [Related]
56. PKCε-dependent H-Ras activation encompasses the recruitment of the RasGEF SOS1 and of the RasGAP neurofibromin in the lipid rafts of embryonic neurons.
Karouzaki S; Peta C; Tsirimonaki E; Mangoura D
Neurochem Int; 2019 Dec; 131():104582. PubMed ID: 31629778
[TBL] [Abstract][Full Text] [Related]
57. Comprehensive RNA Analysis of the NF1 Gene in Classically Affected NF1 Affected Individuals Meeting NIH Criteria has High Sensitivity and Mutation Negative Testing is Reassuring in Isolated Cases With Pigmentary Features Only.
Evans DG; Bowers N; Burkitt-Wright E; Miles E; Garg S; Scott-Kitching V; Penman-Splitt M; Dobbie A; Howard E; Ealing J; Vassalo G; Wallace AJ; Newman W; ; Huson SM
EBioMedicine; 2016 May; 7():212-20. PubMed ID: 27322474
[TBL] [Abstract][Full Text] [Related]
58. Immunoexpression of neurofibromin, S-100 protein, and leu-7 and mutation analysis of the NF1 gene at codon 1423 in osteofibrous dysplasia.
Sakamoto A; Oda Y; Oshiro Y; Tamiya S; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2001 Nov; 32(11):1245-51. PubMed ID: 11727265
[TBL] [Abstract][Full Text] [Related]
59. Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells.
Bollag G; Clapp DW; Shih S; Adler F; Zhang YY; Thompson P; Lange BJ; Freedman MH; McCormick F; Jacks T; Shannon K
Nat Genet; 1996 Feb; 12(2):144-8. PubMed ID: 8563751
[TBL] [Abstract][Full Text] [Related]
60. Affinity Purification of NF1 Protein-Protein Interactors Identifies Keratins and Neurofibromin Itself as Binding Partners.
Carnes RM; Kesterson RA; Korf BR; Mobley JA; Wallis D
Genes (Basel); 2019 Aug; 10(9):. PubMed ID: 31466283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
